Novel serum biomarker of Golgi protein 73 for the diagnosis of clinically significant portal hypertension in patients with compensated cirrhosis

Hepatic venous pressure gradient (HVPG) is the gold standard for evaluating clinically significant portal hypertension (CSPH). However, reliable noninvasive methods are limited. Our study aims to investigate the diagnostic value of serum Golgi protein 73 (GP73) for CSPH in patients with compensated...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of medical virology 2024-01, Vol.96 (1), p.e29380-n/a
Hauptverfasser:	Liu, Shanghao, Ma, Jianzhong, Chen, Ping, Liu, Shirong, Guo, Ying, Tan, Mingjie, Guo, Xiaoqing, Feng, Yinong, Wang, Qinghui, Li, Wenhua, Yang, Chengchen, Gao, Bo, Hua, Yongli, Liu, Ning, Song, Haolin, He, Ruiling, Wang, Ruiying, Gao, Qi, Liu, Chuan, Qi, Xiaolong
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers Cirrhosis Clinical significance clinically significant portal hypertension compensated cirrhosis Confidence intervals Diagnosis Diagnostic systems Elasticity Imaging Techniques Evaluation Golgi apparatus Golgi protein 73 hepatic venous pressure gradient Humans Hypertension Hypertension, Portal - complications Hypertension, Portal - diagnosis Liver Liver cirrhosis Liver Cirrhosis - complications Liver Cirrhosis - diagnosis Proteins Regression analysis ROC Curve Statistical analysis Time Factors Virology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!